MSX-122

DB12715InvestigationalSmall molecule

MSX-122 has been used in trials studying the treatment of Solid Tumors.

Mechanism: Pharmacologically active on C-X-C chemokine receptor type 4
Curator reviewed
Formula / weight: C₁₆H₁₆N₆ · 292.346 g/mol (avg)
Code names: MSX-122

Resolves to

Compound

Structure

InChIKeyPXZXYRKDDXKDTK-UHFFFAOYSA-NSMILESC(NC1=NC=CC=N1)C1=CC=C(CNC2=NC=CC=N2)C=C1

Targets

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with MSX-122, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.